ODOMZO DIN 02500337
Status: Marketed
Holder: SUN PHARMACEUTICAL INDUSTRIES LIMITED
Molecule: SONIDEGIB (SONIDEGIB PHOSPHATE)
Health Canada record
| Active ingredient(s) | SONIDEGIB (SONIDEGIB PHOSPHATE) 200 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01XJ02 SONIDEGIB |
| Original market date | 23-Dec-2020 |
| Current status date | 24-Mar-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sun Pharmaceutical Industries Limited — licence , not currently licensed, last inspection rating C (2026-02-04).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 27329 | 2022-01-04 | New Drug Submission (NDS) | Administrative: Merger/Buy-out |
| 23772 | 2020-06-12 | New Drug Submission (NDS) |